Evaluation of array CGH platforms for clinical diagnostic purposes using idiopathic learning disability as a model condition.

Documents similaires

• Introduction of array CGH into the clinical setting: The Oxford Laboratory experience
  par: Crocker, M, et autres
  Publié: (2006)
• Array-CGH increased the diagnostic rate of developmental delay or intellectual disability in Taiwan
  par: Chung-Lin Lee, et autres
  Publié: (2019-08-01)
• The clinical diagnostic utility of array CGH in children with syndromic microcephaly
  par: Manisha Goyal, et autres
  Publié: (2022-01-01)
• Phenotype in patients with intellectual disability and pathological results in array CGH
  par: V. Caballero Pérez, et autres
  Publié: (2017-11-01)
• The Controversial Molecular Turn in Prenatal Diagnosis. CGH-array Clinical Approaches and Biomedical Platforms
  par: Mauro Turrini
  Publié: (2014-07-01)